injectables

Injecting the Lower Third

Aesthetic practitioners offering minimally invasive injectable treatments for rejuvenation of the lower third of the face should start with soft-tissue fillers to provide structure and support before considering botulinum toxins to reduce fine lines, according to an article by Mauricio de Maio, MD, et al, published in Plastic and Reconstructive Surgery (September 2017). Treatment recommendations offered by the authors of “Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Lower Face” include:

Bacterial Biofilm and Soft-Tissue Fillers

Image of a syringe and ampoule

A study published in Plastic and Reconstructuve Surgery (March 2017) examined bacterial biofilm as a possible cause of adverse nodular reactions following treatment with filler injections. Researchers Mayuran Saththianathan, et al, performed an in vitro analysis of the propensity for three classes of filler materials to support biofilm growth; studied the effect of inoculation of filler material through a contaminated surface; and analyzed biopsy samples from patients presenting with chronic granulomatous inflammation following filler administration.

Allergan Launches Juvéderm Volite

Allergan has launched Juvéderm Volite, a hyaluronic-based injectable filler specifically designed to improve skin quality in the face, neck, décolletage and hands. Volite uses patented Vycross technology and is formulated to last up to nine months with a single treatment session. It should be injected intradermally and contains lidocaine for patient comfort.

Recognizing Complications

Injection-related complications occur among even the most well-trained providers; recognizing the warning signs is key to preventing long-term damage.
Recognizing Complications

The 2015 International Society of Aesthetic Plastic Surgery (ISAPS) Global Procedural Survey revealed that botulinum toxin injections and hyaluronic acid (HA) dermal fillers are the two most popular nonsurgical procedures, with about 4.6 million toxin and 2.8 million filler treatments performed worldwide. The survey results also showed that HA filler popularity is on the rise, as that number represents a 6.5% increase over the previous year.

Lovely Lips

The key to natural-looking lip augmentation lies in understanding facial anatomy and patient expectations.
Lovely Lips

Lip augmentation is one of the few aesthetic concerns that bridges all age groups. Young patients often come to practices seeking larger, more lustrous lips; while aging patients are dismayed at loss of definition and the appearance of perioral lines and wrinkles. In order to create the aesthetic outcomes these patients seek, one must gain an understanding of their desired outcomes and step back to examine the entire lower face.

Easier Aspiration

Main Image: 
Easier Aspiration

The Lee Aspirator is a patent-pending safety device that snaps onto cosmetic injectable syringes, allowing providers to aspirate the syringe with one hand during dermal filler injections. The customized Thumb Ring lets you pull back on the plunger with minimal movement, and the Finger Clip prevents your fingers from sliding during aspiration. The reusable aspirator fits all Juvéderm syringes and is being designed to fit the new Restylane syringe.

Contact: 800.231.7762, www.air-tite.com.

No, don't share this with BeautyEtc
Articles: 
Article free tagging: 

Revance Therapeutics Begins RT002 Studies

Revance Therapeutics commenced a pair of double-blind, placebo-controlled, North American Phase 3 trials to evaluate single injections of drug candidate DaxibotulinumtoxinA (RT002) for the treatment of glabellar lines in about 600 total patients. The trials follow the successful BELMONT study that showed RT002 delivered six-month duration of effect, with no ptosis at the 40-unit level, in treating frown lines.

Maximizing Safety During Facial Fillers

Maximizing Safety During Facial Fillers

In an article published in Plastic and Reconstructive Surgery (January 2017), Jack F. Scheuer III, MD, et al, outline general principles and safe practices for ensuring increased safety and better outcomes when administering facial filler injections. They posit that practitioners can tailor injection techniques to prevent vessel injury and avoid cannulation by considering the depth and the location of the vasculature within six “facial danger zones,” i.e., brows/glabella, temporal region, infraorbital area, lips/commissure, nasolabial folds and nose.

FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers

FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers

Galderma has received U.S. Food and Drug Administration (FDA) approval of two new Restylane products for the treatment of nasolabial folds (NLF) in patients over the age of 21. Restylane Refyne is approved for the treatment of moderate to severe facial wrinkles and folds, and Restylane Defyne for the treatment of moderate to severe, deep facial wrinkles and folds.